- Home
- CZR vs VKTX Comparison
CZR vs VKTX Comparison
Compare CZR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- VKTX
- Stock Information
- Founded
- CZR 1937
- VKTX 2012
- Country
- CZR United States
- VKTX United States
- Employees
- CZR N/A
- VKTX N/A
- Industry
- CZR Hotels/Resorts
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- VKTX Health Care
- Exchange
- CZR Nasdaq
- VKTX Nasdaq
- Market Cap
- CZR 4.6B
- VKTX 3.8B
- IPO Year
- CZR 1989
- VKTX 2015
- Fundamental
- Price
- CZR $18.73
- VKTX $35.22
- Analyst Decision
- CZR Strong Buy
- VKTX Strong Buy
- Analyst Count
- CZR 14
- VKTX 14
- Target Price
- CZR $39.36
- VKTX $87.00
- AVG Volume (30 Days)
- CZR 8.4M
- VKTX 4.8M
- Earning Date
- CZR 10-28-2025
- VKTX 10-22-2025
- Dividend Yield
- CZR N/A
- VKTX N/A
- EPS Growth
- CZR N/A
- VKTX N/A
- EPS
- CZR N/A
- VKTX N/A
- Revenue
- CZR $11,369,000,000.00
- VKTX N/A
- Revenue This Year
- CZR $3.49
- VKTX N/A
- Revenue Next Year
- CZR $3.00
- VKTX N/A
- P/E Ratio
- CZR N/A
- VKTX N/A
- Revenue Growth
- CZR 0.87
- VKTX N/A
- 52 Week Low
- CZR $18.64
- VKTX $18.92
- 52 Week High
- CZR $45.65
- VKTX $79.10
- Technical
- Relative Strength Index (RSI)
- CZR 26.31
- VKTX 60.22
- Support Level
- CZR $21.44
- VKTX $33.00
- Resistance Level
- CZR $23.37
- VKTX $36.11
- Average True Range (ATR)
- CZR 0.95
- VKTX 2.02
- MACD
- CZR -0.17
- VKTX 0.09
- Stochastic Oscillator
- CZR 1.80
- VKTX 73.40
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.